1-13 of 13
Su Yang
Close
Sort by
Journal Articles

Preliminary Safety and Efficacy of Relmacabtagene Autoleucel (relma-cel) in Adults with Relapsed/Refractory Mantle Cell Lymphoma (r/r MCL) in China

Zhitao Ying, Keshu Zhou, Lanfang Li, Wenyu Li, Su Yang, Yun Liu, Yongen Gu, Zisong Zhou, Alex Tian, Yuqin Song, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 7470–7471.
https://doi.org/10.1182/blood-2022-164525
Published: 2022
Journal Articles

Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Alex Tian, Tony Huang, Zisong Zhou, Meilin Ma, Su Yang, Yun Qin, Jun Zhu
Journal: Blood
Blood (2022) 140 (Supplement 1): 10329–10331.
https://doi.org/10.1182/blood-2022-162985
Published: 2022
Journal Articles

Primary Clinical Response of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma (r/r FL) in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Su Yang, Pian Zhang, Meilin Ma, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2434.
https://doi.org/10.1182/blood-2021-150085
Published: 2021
Journal Articles

Relmacabtagene Autoleucel CD19 CART Therapy for Adults with Heavily-Pretreated Relapsed/Refractory Large B-Cell Lymphoma in China

Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Daobin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Jun Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3557.
https://doi.org/10.1182/blood-2021-148358
Published: 2021
Journal Articles

Clinical Response of CD19 CAR-T Cells (relmacabtagene autoleucel, relma-cel) in Adults with Heavily-Pre-Treated Relapsed/Refractory (r/r) Large B-Cell Lymphoma in China

Jun Zhu, MD, Zhitao Ying, MD, Yuqin Song, MD PhD, Haiyan Yang, MD PhD, Ye Guo, MD, Wenyu Li, PhD, Dehui Zou, MD, Daobin Zhou, MD PhD, Zhao Wang, MD, Mingzhi Zhang, MD, Jianqiu Wu, MD, Hui Liu, MD, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-136038
Published: 2020
Journal Articles

Clinical Response in Relapsed/Refractory (R/R) B-NHL Treated with the CD19-Directed CAR T-Cell Product JWCAR029

Zhitao Ying, MD PhD, Pengpeng Xu, MD, Li Wang, MD PhD, Shu Cheng, MD PhD, Wen Wu, MD PhD, Wen Wang, MD PhD, Ming Hao, PhD, Su Yang, Harry Lam, PhD, James Li, Hongxia Zheng, MD PhD, Weili Zhao, MD PhD, Yuqin Song, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 2876.
https://doi.org/10.1182/blood-2019-127751
Published: 2019
Journal Articles

Cellular Kinetics and Anti-Therapeutic Antibody in Relapsed/Refractory B-NHL Patients Treated with JWCAR029

Zhitao Ying, MD PhD, Pengpeng Xu, MD, Ming Hao, PhD, Li Wang, MD PhD, Shu Cheng, MD PhD, Wen Wu, MD PhD, Wen Wang, MD PhD, Zisong Zhou, Su Yang, Jennifer Wang, PhD, Harry Lam, PhD, James Li, Hongxia Zheng, MD PhD, Weili Zhao, MD PhD, Yuqin Song, MD PhD, Jun Zhu, BS
Journal: Blood
Blood (2019) 134 (Supplement_1): 4083.
https://doi.org/10.1182/blood-2019-126408
Published: 2019
Journal Articles

JWCAR029 Is a CD19-Targeted CAR T Cell Product with Process and Quality Controls Delivered As a Flat Dose of CAR T Cell to Patients with NHL

Wen Wang, MD, Ming Hao, Yin Cheng, PhD, Juan Gao, MSc, Su Yang, Yanwei Liu, BSc, Harry Lam, PhD, Shuyuan Yao, PhD, James Li
Journal: Blood
Blood (2018) 132 (Supplement 1): 5387.
https://doi.org/10.1182/blood-2018-99-114434
Published: 2018
Journal Articles

CD19 CAR T Cell Product Exhibits High Remission Rate in Adult Relapsed and/or Refractory B-Cell Non-Hodgkin Lymphoma

Zhitao Ying, MD PhD, Wen Wang, MD, Xiaopei Wang, MD, Wen Zheng, MD, Ningjing Lin, MD PhD, Meifeng Tu, MD PhD, Yan Xie, MD PhD, Lingyan Ping, MD PhD, Chen Zhang, MD PhD, Weiping Liu, MD PhD, Lijuan Deng, MD PhD, Ming Hao, Su Yang, Yan Zhou, BSc, James Li, Yuqin Song, MD PhD, Jun Zhu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5388.
https://doi.org/10.1182/blood-2018-99-114527
Published: 2018
Journal Articles

Efficacy and Safety of JWCAR029 in Adult Patients with Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma

Zixun Yan, Wen Wang, MD, Zhong Zheng, Ming Hao, Su Yang, James Li, Shu Cheng, Li Wang, Wei-li Zhao
Journal: Blood
Blood (2018) 132 (Supplement 1): 4187.
https://doi.org/10.1182/blood-2018-99-115769
Published: 2018
Journal Articles

Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg FISH) Enhances the Quantitative Detection of Chromosome Abnormalities In Plasma Cell Neoplasms Compared to Conventional FISH

Hai-Su Yang, Ph.D, Josephine Montella, Laura Holt, Christine Stephenson, Ph.D., FACMG, Pauline Brenholz, MD, Guoxian Sun, MD, Carol Berger, Thomas Scholl, Ph.D, Ajai Chari, MD, Amitabha Mazumder, MD, Sundar Jagannath, MD, Henry Y. Dong, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 1198.
https://doi.org/10.1182/blood.V116.21.1198.1198
Published: 2010
Journal Articles

Human Cord Blood Cells Are Capable of Generating Amylase-Producing Pancreatic Acinar Cells without Cell Fusion.

Hitoshi Minamiguchi, Fumihiko Ishikawa, Paul A. Fleming, Su Yang, Christopher J. Drake, Makio Ogawa
Journal: Blood
Blood (2005) 106 (11): 1707.
https://doi.org/10.1182/blood.V106.11.1707.1707
Published: 2005
Journal Articles

Hematopoietic Origin of Fibroblasts and Their Precursors.

Yasuhiro Ebihara, Masahiro Masuya, Russell Owens, Su Yang, Richard P. Visconti, Paul A. Fleming, Hitoshi Minamiguchi, Christopher J. Drake, Makio Ogawa
Journal: Blood
Blood (2004) 104 (11): 672.
https://doi.org/10.1182/blood.V104.11.672.672
Published: 2004